Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials (Q91853): Difference between revisions
From MaRDI portal
Created a new Item |
Changed an Item |
||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Revision as of 15:37, 14 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Two-stage designs optimal under the alternative hypothesis for phase II cancer clinical trials |
scientific article |
Statements
31
0 references
6
0 references
572-578
0 references
November 2010
0 references
